Integral Diagnostics Ltd
ASX:IDX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.66
3.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Integral Diagnostics Ltd
Net Margin
Integral Diagnostics Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | AU |
| Market Cap | 678.4m AUD |
| Net Margin |
-13%
|
| Country | US |
| Market Cap | 91.8B USD |
| Net Margin |
1%
|
| Country | US |
| Market Cap | 87.7B EUR |
| Net Margin |
1%
|
| Country | US |
| Market Cap | 73B USD |
| Net Margin |
1%
|
| Country | DE |
| Market Cap | 24.9B EUR |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 20.1B USD |
| Net Margin |
3%
|
| Country | DE |
| Market Cap | 18.8B EUR |
| Net Margin |
-2%
|
| Country | US |
| Market Cap | 18.3B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 13.7B USD |
| Net Margin |
7%
|
| Country | DE |
| Market Cap | 12.4B EUR |
| Net Margin |
3%
|
| Country | AU |
| Market Cap | 13.4B AUD |
| Net Margin |
6%
|
Integral Diagnostics Ltd
Glance View
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Integral Diagnostics Ltd's most recent financial statements, the company has Net Margin of -12.9%.
You don't have any saved screeners yet
